European network on Myalgic encephalomyelitis/Chronic fatigue syndrome

Project Details

Description

The main aim of the project is to establish a sustainable, integrated European researchers’ network in the field of myalgic encephalomyelitis/chronic fatigue syndrome to address the research issues of unknown aetiology, clinical variability, lack of diagnostic biomarkers and limited treatment options that have significant negative socio-economic impact on national economy.
COST (European Cooperation in Science and Technology) activity European Network on Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome, (EUROMENE) was established in 2016. Initially 11 countries of the European Union (Belgium, Bulgaria, France, Germany, Italy, Latvia, Norway, Romania, Serbia, Spain, United Kingdom) and Belarus took part in this activity.
RSU Microbiology and Virology Institute (MVI), as the project’s initiator, represents Latvia in COST activity and has been approved as the project coordinator and the beneficiary of financing. Professor M. Murovska, director of Institute of Microbiology and Virology, was elected as the chairperson of the COST activity 15111 EUROMENE.
Chronic fatigue syndrome is a complicated disease characterised by chronic fatigue, muscle pain, weakness, issues related to memory and concentration. Implementation of EUROMENE project will result in reflection of CFS possible treatment methods, enabling patients to recover faster from this disease.
AcronymEUROMENE
StatusFinished
Effective start/end date21/04/1620/04/21

Funding

  • European Commission: €431,268.20

Keywords

  • ME/CFS
  • clinical features
  • biomarkers
  • epidemiology
  • socio-economics

Field of Science

  • 3.3 Health sciences

Smart Specialization Area

  • Biomedicine, medical technologies and biotechnology